| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| Other Sizes |
| Targets |
Target: Not established (bioactive natural product). Scopoline is a tropane alkaloid that is formed from scopine, its epimer. The specific protein targets of Scopoline have not been identified in the literature. It is known to have fungitoxic effects, suggesting antifungal activity, but the molecular mechanism is not characterized. It is primarily used as a reference compound and analytical standard in natural product chemistry.
|
|---|---|
| ln Vitro |
In vitro, Scopoline has been reported to have fungitoxic effects against certain fungal species. No specific IC50 or EC50 values have been reported. As an alkaloid from Datura species, it may have weak anticholinergic or CNS activity, but detailed pharmacological characterization is lacking. No cell-based studies have been published. No in vitro activity data are available.
|
| ln Vivo |
No in vivo efficacy data have been published for Scopoline. As a natural product, it may have been studied in traditional medicine contexts, but modern pharmacological studies have not been reported. No animal studies are available.
|
| Enzyme Assay |
No cell-free assays have been reported for Scopoline. As a research compound, it is typically used as a reference standard in analytical chemistry, not as a pharmacological probe in enzyme or receptor binding assays. Its identity is confirmed by NMR and HPLC-MS, but no specific biological assays have been standardized.
|
| Cell Assay |
No cell-based assays have been performed with Scopoline in modern pharmacological research. The compound may be used as a negative control or reference standard in natural product studies, but no cell culture protocols have been published.
|
| Animal Protocol |
No animal studies have been conducted with Scopoline. The compound is for research use only and is not intended for in vivo administration. No animal efficacy or safety studies have been reported.
|
| ADME/Pharmacokinetics |
PK properties of Scopoline have not been reported. As a tropane alkaloid (MW 155.19, LogP ∼0.5), it is expected to be water-soluble and may be absorbed via passive diffusion. It may cross the blood-brain barrier due to the tropane scaffold (similar to scopolamine). However, no formal PK studies have been performed. The compound is for research use only and not for human administration.
|
| Toxicity/Toxicokinetics |
No toxicity data have been reported for Scopoline. As a naturally occurring alkaloid, it may have toxicity at high doses, but no LD50 or acute toxicity studies have been published. The compound is for research use only and is not intended for human consumption. It should be handled with appropriate safety precautions (gloves, goggles, lab coat). Non-hazardous for transport under normal laboratory conditions.
|
| References | |
| Additional Infomation |
Scopoline is a research compound and not an approved drug. It is not FDA-approved for clinical use. It is used as an analytical reference standard in natural product chemistry, alkaloid profiling, and metabolomics studies. It may be used in quality control for herbal extracts containing Datura species or other tropane alkaloids. It is also used as a precursor in organic synthesis for the preparation of other tropane derivatives.
|
| Molecular Formula |
C8H13NO2
|
|---|---|
| Molecular Weight |
155.1943
|
| Exact Mass |
155.095
|
| CAS # |
487-27-4
|
| PubChem CID |
261184
|
| Appearance |
White to off-white solid powder
|
| Density |
1.284 g/cm3
|
| Boiling Point |
248ºCat 760 mmHg
|
| Melting Point |
107-109ºC
|
| Flash Point |
111.6ºC
|
| Vapour Pressure |
0.00403mmHg at 25°C
|
| Index of Refraction |
1.573
|
| LogP |
-0.2
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
0
|
| Heavy Atom Count |
11
|
| Complexity |
197
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
MEGPURSNXMUDAE-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C8H13NO2/c1-9-5-2-4-3-6(9)8(11-4)7(5)10/h4-8,10H,2-3H2,1H3
|
| Chemical Name |
6-methyl-2-oxa-6-azatricyclo[3.3.1.03,7]nonan-4-ol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.4437 mL | 32.2186 mL | 64.4371 mL | |
| 5 mM | 1.2887 mL | 6.4437 mL | 12.8874 mL | |
| 10 mM | 0.6444 mL | 3.2219 mL | 6.4437 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
